You have 9 free searches left this month | for more free features.

City

Paris (1)

Condition

Myelofibrosis (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

French Innovative Leukemia Organisation (1)

Collaborator

Intervention

ruxolotinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

ruxolotinib

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Myelofibrosis Trial in Paris (Ruxolotinib)

Completed

Myelofibrosis

Ruxolotinib

Paris, France

ROBIN

Jul 26, 2022